Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions (Vac09)

This study has been completed.
Sponsor:
Collaborators:
European Union
The Swedish Research Council
Läkare mot AIDS Forskningsfond
Information provided by:
Swedish Institute for Infectious Disease Control
ClinicalTrials.gov Identifier:
NCT01140139
First received: June 7, 2010
Last updated: June 8, 2010
Last verified: February 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)